Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Sucampo Pharmaceuticals, Inc. 

4733 Bethesda Avenue
Suite 450
Bethesda  Maryland  20814  U.S.A.
Phone: 301-961-3400 Fax: 301-961-3440



Start Up

 Company News
Sucampo (SCMP) Announces Clinical Data On Lubiprostone To Be Presented At Digestive Disease Week 5/17/2015 4:51:21 PM
Sucampo (SCMP) Announces Webcast Of Its Presentation At The 2015 UBS Global Healthcare Conference 5/14/2015 10:30:48 AM
Sucampo (SCMP) And Harbin Gloria Pharmaceuticals (002437.SZ) Enter Into Licensing Agreement For AMITIZA (Lubiprostone) In China 5/11/2015 3:58:43 PM
FDA Grants Fast Track Designation To Sucampo (SCMP)'s Cobiprostone For Oral Mucositis 5/8/2015 7:59:08 AM
R-Tech Ueno, Sucampo (SCMP) Dissolve Unoprostone Pacts 5/7/2015 6:04:53 AM
Sucampo (SCMP) Announces First Quarter 2015 Earnings Call 4/22/2015 1:15:49 PM
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR 4/13/2015 10:46:01 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 14th Annual Needham Healthcare Conference 4/7/2015 7:45:36 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Proposed Public Offering By Selling Stockholders 3/26/2015 10:52:26 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Prices Public Offering Of Common Stock By Selling Stockholders 3/26/2015 10:32:02 AM